These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2848680)

  • 1. [Biochemical effects of electroconvulsotherapy].
    Benkelfat C
    Encephale; 1988; 14(4):273-81. PubMed ID: 2848680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
    Lerer B
    Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role of some central neurotransmitter systems in the mechanism of electroconvulsive shock action.
    Kleinrok Z; Wielosz M
    Pol J Pharmacol Pharm; 1985; 37(6):745-52. PubMed ID: 3008135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors and the mechanism of action of ECT.
    Lerer B; Belmaker RH
    Biol Psychiatry; 1982 Apr; 17(4):497-511. PubMed ID: 6282347
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurobiological correlates of the antidepressant action of electroconvulsive therapy.
    Mann JJ
    J ECT; 1998 Sep; 14(3):172-80. PubMed ID: 9773356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of neurotransmitters to the symptoms of major depressive disorder.
    Nutt DJ
    J Clin Psychiatry; 2008; 69 Suppl E1():4-7. PubMed ID: 18494537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of biochemical basis of the antidepressant action of electroconvulsive therapy by human studies.
    Mann JJ; Kapur S
    Psychopharmacol Bull; 1994; 30(3):445-53. PubMed ID: 7878181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical strategies for evaluating ECT mechanisms--pharmacological, biochemical and psychophysiological approaches.
    Lerer B; Sitaram N
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):309-33. PubMed ID: 6137030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical mechanisms of action of ECS: evidence from in vivo studies.
    Newman ME; Gur E; Shapira B; Lerer B
    J ECT; 1998 Sep; 14(3):153-71. PubMed ID: 9773355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new concept of antidepressant drugs action: clinical and preclinical data].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1994; 28(1):39-50. PubMed ID: 7910691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action.
    Sackeim HA; Decina P; Prohovnik I; Malitz S; Resor SR
    Biol Psychiatry; 1983 Nov; 18(11):1301-10. PubMed ID: 6317065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gabaergic and serotoninergic systems on hypothalamic content of catecholamines during sexual development in female rats.
    Rondina D; Ponzo OJ; Szwarcfarb B; Carbone S; Scacchi P; Moguilevsky JA
    Neuro Endocrinol Lett; 2003; 24(1-2):46-9. PubMed ID: 12743531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of electroconvulsive shock seizures on behaviour induced by dopaminergic agonists and on immobility in the Porsolt test.
    Zarrindast MR; Sahebgharani M; Burnham WM
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):509-14. PubMed ID: 15589391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of activity-regulated cytoskeleton protein (Arc) mRNA after acute and chronic electroconvulsive stimulation in the rat.
    Larsen MH; Olesen M; Woldbye DP; Hay-Schmidt A; Hansen HH; Rønn LC; Mikkelsen JD
    Brain Res; 2005 Dec; 1064(1-2):161-5. PubMed ID: 16309632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain neurotransmitter receptor binding and nootropic studies on Indian Hypericum perforatum Linn.
    Kumar V; Khanna VK; Seth PK; Singh PN; Bhattacharya SK
    Phytother Res; 2002 May; 16(3):210-6. PubMed ID: 12164263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion: a review of its mechanism of antidepressant activity.
    Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
    J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of electroconvulsive shock on central GABA-ergic mechanisms.
    Wielosz M; Stelmasiak M; Ossowska G; Kleinrok Z
    Pol J Pharmacol Pharm; 1985; 37(2):113-22. PubMed ID: 2995953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of electroconvulsive therapy on plasma GABA.
    Devanand DP; Shapira B; Petty F; Kramer G; Fitzsimons L; Lerer B; Sackeim HA
    Convuls Ther; 1995 Mar; 11(1):3-13. PubMed ID: 7796065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic stimulation of the brain in animal depression models responsive to ECS.
    Belmaker RH; Grisaru N
    J ECT; 1998 Sep; 14(3):194-205. PubMed ID: 9773358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electroconvulsive therapy in the treatment of Parkinson disease].
    Jeanneau A
    Encephale; 1993; 19(5):573-8. PubMed ID: 8306926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.